These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18446474)

  • 21. Development of cyclosporine A microemulsion for parenteral delivery.
    Yuan Y; Che X; Zhao M; Wang Y; Liu Y; Schwendeman A; Li S
    J Microencapsul; 2015; 32(3):273-80. PubMed ID: 25761521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel, lipid-free nanodispersion formulation of propofol and its characterization.
    Chen H; Zhang Z; Almarsson O; Marier JF; Berkovitz D; Gardner CR
    Pharm Res; 2005 Mar; 22(3):356-61. PubMed ID: 15835740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physicochemical Characterization and Pharmacological Evaluation of Novel Propofol Micelles with Low-Lipid and Low-Free Propofol.
    Chu Y; Sun T; Xie Z; Sun K; Jiang C
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicochemical and drug delivery aspects of lipid-based liquid crystalline nanoparticles: a case study of intravenously administered propofol.
    Johnsson M; Barauskas J; Norlin A; Tiberg F
    J Nanosci Nanotechnol; 2006; 6(9-10):3017-24. PubMed ID: 17048513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of pain and irritation following local administration of parenteral formulations using the rat paw lick model.
    Gupta PK; Patel JP; Hahn KR
    J Pharm Sci Technol; 1994; 48(3):159-66. PubMed ID: 8069518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized microemulsions and solid microemulsion systems of simvastatin: characterization and in vivo evaluation.
    Dixit RP; Nagarsenker MS
    J Pharm Sci; 2010 Dec; 99(12):4892-902. PubMed ID: 20648662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pain on propofol injection: Causes and remedies.
    Desousa KA
    Indian J Pharmacol; 2016; 48(6):617-623. PubMed ID: 28066096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of new propofol aqueous solutions for intravenous anesthesia.
    Trapani A; Laquintana V; Lopedota A; Franco M; Latrofa A; Talani G; Sanna E; Trapani G; Liso G
    Int J Pharm; 2004 Jun; 278(1):91-8. PubMed ID: 15158952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
    Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
    Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting solubilisation features of ternary phase diagrams of fully dilutable lecithin linker microemulsions.
    Nouraei M; Acosta EJ
    J Colloid Interface Sci; 2017 Jun; 495():178-190. PubMed ID: 28199856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and evaluation of nitrendipine nanoemulsion for intranasal delivery.
    Jain R; Patravale VB
    J Biomed Nanotechnol; 2009 Feb; 5(1):62-8. PubMed ID: 20055107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parenteral microemulsions: an overview.
    Date AA; Nagarsenker MS
    Int J Pharm; 2008 May; 355(1-2):19-30. PubMed ID: 18295991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
    Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
    J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of microemulsion based topical ivermectin formulations: Pre-formulation and formulation studies.
    Das S; Lee SH; Chia VD; Chow PS; Macbeath C; Liu Y; Shlieout G
    Colloids Surf B Biointerfaces; 2020 May; 189():110823. PubMed ID: 32036331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate.
    Patel AR; Vavia PR
    AAPS J; 2007 Oct; 9(3):E344-52. PubMed ID: 18170981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applications of microemulsion based drug delivery system.
    Jadhav KR; Shaikh IM; Ambade KW; Kadam VJ
    Curr Drug Deliv; 2006 Jul; 3(3):267-73. PubMed ID: 16848728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation, characterization, sterility validation, and in vitro cell toxicity studies of microemulsions possessing potential parenteral applications.
    Nesamony J; Zachar CL; Jung R; Williams FE; Nauli S
    Drug Dev Ind Pharm; 2013 Feb; 39(2):240-51. PubMed ID: 22480266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation development of parenteral phospholipid-based microemulsion of etoposide.
    Jain J; Fernandes C; Patravale V
    AAPS PharmSciTech; 2010 Jun; 11(2):826-31. PubMed ID: 20464537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
    Üstündağ Okur N; Çağlar EŞ; Siafaka PI
    J Ocul Pharmacol Ther; 2020; 36(6):342-354. PubMed ID: 32255728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.